 "Dishman Pharma hits 52-week high on strong Q1 results")
Dishman Pharmaceuticals & Chemicals has rallied 5% to Rs 233, extending its previous day’s 6% surge on the BSE, after reported a strong 59% year-on-year (Y-o-Y) growth in consolidated net profit at Rs 37.76 crore for the quarter ended June 30, 2015 (Q1), on account of lower raw material cost. The company had profit of Rs 23.81 crore in a year ago quarter.
Net sales grew by 10% at Rs 400 crore on Y-o-Y basis. The raw material cost nearly halved from Rs 188 crore to Rs 101 crore during the recently concluded quarter.
The stock opened at Rs 227 and touched a 52-week high of Rs 235 on the BSE. A combined 907,178 shares changed hands on the counter on the NSE and BSE till 09:30 AM.
Net sales grew by 10% at Rs 400 crore on Y-o-Y basis. The raw material cost nearly halved from Rs 188 crore to Rs 101 crore during the recently concluded quarter.
The stock opened at Rs 227 and touched a 52-week high of Rs 235 on the BSE. A combined 907,178 shares changed hands on the counter on the NSE and BSE till 09:30 AM.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%